HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Barr, FDA Will Meet On Plan B Switch; Agency Says Rulemaking Not Needed

This article was originally published in The Tan Sheet

Executive Summary

The approval process for the over-the-counter sale of Barr's emergency contraceptive Plan B could be "wrapped up in a matter of weeks if [Barr and FDA] work diligently" together, according to an FDA spokesperson

You may also be interested in...



FDA Morale Improvement Will Be A Priority, Von Eschenbach Testifies

Acting Commissioner Andrew von Eschenbach stressed his commitment to improving agency morale during his confirmation hearing

FDA “Unable” To Decide On Plan B, Seeks Comment On Dual-Status Drugs

FDA believes additional information on whether a drug can be marketed both Rx and OTC for the same indication is needed before a decision can be reached on Barr Labs' switch application for Plan B

FDA Panels Debate Pricing, Promotions For Plan B OTC

Barr Laboratories' efforts to increase access to its emergency contraceptive Plan B should include measures to make the drug accessible to women who cannot afford the morning-after pill, some panelists said at a joint meeting of the Nonprescription Drugs and Reproductive Health Drugs advisory committees in Gaithersburg, Md. Dec. 16

Topics

UsernamePublicRestriction

Register

RS125755

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel